HYDROCODONE BITARTRATE AND ACETAMINOPHEN tablet 미국 - 영어 - NLM (National Library of Medicine)

hydrocodone bitartrate and acetaminophen tablet

sun pharmaceutical industries, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 5 mg - hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve hydrocodone bitartrate and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with: hydrocodone bitartrate and acetaminophen tablets contain hydrocodone, a schedule ii controlled substance. hydrocodone bitartrate and acetaminophen tablets contain hydrocodone, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol, can be abused and is subject to misuse, addiction, and criminal diversion [see warnings ]. all patients treated with o

VENLAFAXINE tablet 미국 - 영어 - NLM (National Library of Medicine)

venlafaxine tablet

sun pharmaceutical industries, inc. - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 25 mg - venlafaxine tablets, usp is indicated for the treatment of major depressive disorder. the efficacy of venlafaxine tablets, usp in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iii-r category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the efficacy of 

OXYCODONE AND ACETAMINOPHEN- oxycodone and acetaminophen tablet 미국 - 영어 - NLM (National Library of Medicine)

oxycodone and acetaminophen- oxycodone and acetaminophen tablet

sun pharmaceutical industries, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg - oxycodone hydrochloride and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] oxycodone hydrochloride and acetaminophen tablets is contraindicated in patients with: controlled substance oxycodone hydrochloride and acetaminophen tablets n contain oxycodone, a schedule ii controlled substance. abuse oxycodone hydrochloride and acetaminophen tablets contains oxycodone, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxymorphone, and tapentadol. oxycodone hydrochloride and acetaminophen tablets can be abused and is subject to misuse

PLAQCLNZ GEL zinc gluconate 미국 - 영어 - NLM (National Library of Medicine)

plaqclnz gel zinc gluconate

addison biological laboratory, inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - zinc gluconate 0.974 g in 1 ml

ZICAM COLD REMEDY ULTRA RAPIDMELTS zinc acetate anhydrous and gluconate tablet multilayer 미국 - 영어 - NLM (National Library of Medicine)

zicam cold remedy ultra rapidmelts zinc acetate anhydrous and gluconate tablet multilayer

matrixx initiatives, inc. - zinc acetate anhydrous (unii: h2zey72pme) (zinc - unii:j41csq7qds) - zinc acetate anhydrous 2 [hp_x]

ZICAM ULTRA COLD REMEDY RAPIDMELTS zinc acetate anhydrous and gluconate tablet 미국 - 영어 - NLM (National Library of Medicine)

zicam ultra cold remedy rapidmelts zinc acetate anhydrous and gluconate tablet

matrixx initiatives, inc. - zinc acetate anhydrous (unii: h2zey72pme) (zinc cation - unii:13s1s8sf37) - zinc cation 2 [hp_x]

NBB CHERRY- zinc gluconate, zinc oxide, and sambucus nigra flower tablet, orally disintegrating 미국 - 영어 - NLM (National Library of Medicine)

nbb cherry- zinc gluconate, zinc oxide, and sambucus nigra flower tablet, orally disintegrating

dynamic pharmaceuticals inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), sambucus nigra flower (unii: 07v4dx094t) (sambucus nigra flower - unii:07v4dx094t) - zinc gluconate 1 [hp_x] - - reduces duration of common cold - reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion

NBE COOL MINT COLD REMEDY FAST MELTING- zinc gluconate lozenge 미국 - 영어 - NLM (National Library of Medicine)

nbe cool mint cold remedy fast melting- zinc gluconate lozenge

dynamic pharmaceuticals inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds) - zinc gluconate 1 [hp_x] - reduces duration and severity of the common cold - reduces duration of common cold - reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion

NBE CITRUS- zinc acetate and zinc gluconate tablet, orally disintegrating 미국 - 영어 - NLM (National Library of Medicine)

nbe citrus- zinc acetate and zinc gluconate tablet, orally disintegrating

dynamic pharmaceuticals inc. - zinc acetate (unii: fm5526k07a) (zinc - unii:j41csq7qds), zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds) - zinc acetate 2 [hp_x] - - reduces duration of the common cold - reduces severity of cold symptoms: sore throat, stuffy nose, sneezing, coughing, and congestion

TEMAZEPAM capsule 미국 - 영어 - NLM (National Library of Medicine)

temazepam capsule

sun pharmaceutical industries, inc. - temazepam (unii: chb1qd2qss) (temazepam - unii:chb1qd2qss) - temazepam 7.5 mg - temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). for patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). the clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment. benzodiazepines may cause fetal harm when administered to a pregnant woman. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. reproduction studies in animals with temazepam were performed in rats and rabbits. in a perinatal- postnatal study in rats, oral doses of 60 mg/kg/day resul